Year: 2025

VANCOUVER, British Columbia, Jan. 13, 2025 (GLOBE NEWSWIRE) — Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company”), an emerging North American uranium and lithium exploration company, is pleased to announce that the Company has obtained a final order from the Supreme Court of British Columbia approving the proposed plan of arrangement (the “Arrangement”) under which the Company will spin-out its gold and silver properties located in Sierra County, New Mexico, United States (collectively, the “Winston Property”) to shareholders through Rio Grande Resources Ltd. (“Rio Grande”), a wholly-owned subsidiary of the Company. The Arrangement was previously approved by 99.86% of votes cast by Foremost shareholders (the “Shareholders”) at the annual general and special meeting of Shareholders held on December...

White Label Partnership Enters its 2nd Year SCHAUMBURG, IL, Jan. 13, 2025 (GLOBE NEWSWIRE) — Giftify, Inc. (NASDAQ: GIFT) (the “Company”), the owner and operator of leading digital platforms, CardCash.com and Restaurant.com, with a focus on incentives and rewards in retail, dining & entertainment experiences, is pleased to announce its white label partnership with CVS, powering their CVS Gift Card Exchange is now entering its 2nd year. The platform that enables CVS to accept unwanted gift cards for store e-credit is accessible here:https://cvs.cardcash.com. Ketan Thakker, Chief Executive Officer of Giftify, Inc., commented, “We are pleased to enter our second year working together with CVS in enabling their gift card exchange program. More and more retailers are aligning with our vision in that when they’re well-chosen,...

Achieves 35% year-over-year growth to 209,900 members on Jan. 1, showing how Medicare Advantage can be done right Announces year-end 2025 health plan membership of 225,000 to 231,000 and reiterates confidence in achieving consensus adjusted EBITDA of $40 million in 2025ORANGE, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) — Alignment Healthcare, Inc. (NASDAQ: ALHC), an award-winning Medicare Advantage (MA) company, today announced Jan. 1 health plan membership of approximately 209,900, representing a 35% year-over-year increase in health plan membership when compared to membership as of Jan. 1, 2024. Additionally, the company expects to have 225,000 to 231,000 health plan members as of Dec. 31, 2025, representing growth of approximately 22% to 25% relative to the midpoint of its year-end 2024 membership guidance provided on Oct. 29,...

TORONTO, Jan. 13, 2025 (GLOBE NEWSWIRE) — Bloom Investment Counsel, Inc. (the “Manager”), the manager of Bloom Select Income Fund (TSX: BLB.UN) (the “Fund”), announced today that the Fund will terminate on March 5, 2025 (the “Termination”). Despite the Fund’s positive performance since inception, the Board of Directors of the Manager has determined that the Termination is in the best interests of the Fund and of the unitholders of the Fund because of the Fund’s small size, which has increased the MER and reduced trading liquidity for the Fund’s unitholders. On or before March 19, 2025, the Fund will distribute to each unitholder, in cash, their pro-rata share of the net assets of the Fund after all liabilities of the Fund have been paid or provided for. An application for voluntary delisting of the Fund’s units from the TSX has...

Study to be conducted under $3.6 million NIH grant  DENVER, Jan. 13, 2025 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) application to evaluate the safety and initial efficacy of SeaStar Medical’s Selective Cytopheretic Device (SCD-ADULT) in reducing inflammation in adult patients with acute heart failure with worsening renal function due to cardiorenal syndrome or severe right ventricular failure awaiting a left ventricular assist device (LVAD) implantation. This feasibility study is expected to enroll 20 patients at up to five clinical sites and will be...

Petah Tikvah, Israel, Jan. 13, 2025 (GLOBE NEWSWIRE) — SaverOne 2014 Ltd. (Nasdaq: SVRE, TASE: SVRE), a technology leader in advanced transportation safety solutions, is pleased to announce a new distribution agreement with uniSmart Vertriebs GmbH (“uniSmart”), a prominent German-based distributor specializing in fleet safety and technology integration. uniSmart, headquartered in Wendendelstein, provides solutions for logistics and transportation companies across Germany and abroad. The company resells, installs, and provides support for advanced fleet management and safety systems, including Webfleet technology, for a variety of fleet sizes and industries. uniSmart’s client base includes major national German transport operators and many medium-sized fleets. Mr. Ori Gilboa, CEO of SaverOne, commented, “We continue our strong...

THE WOODLANDS, TX, Jan. 13, 2025 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced its abstract has been accepted for poster presentation at the SIO 2025 Annual Scientific Meeting, being held January 30 – February 3, 2025 in Las Vegas, NV. Details of the accepted abstract are as follows: Title: Ablation of the Celiac Ganglia for Treatment of Pancreatic Cancer Pain: An Interim Analysis of the First Five “Lead-In” PatientsAuthor: Rob Schwartz, M.D., Chief Medical Officer of Autonomix SIO is a non-profit organization dedicated to promoting and supporting the field of interventional oncology (IO), aiming to establish it as...

– Topline data from the first Phase 3 FOS study anticipated in H2 2025 representing major milestone in support of NDA filing and potential launch of azetukalner – First of three planned Phase 3 MDD studies now initiated – Expanding ion channel portfolio includes Kv7 and Nav1.7 candidates advancing towards IND filings in 2025 VANCOUVER, British Columbia and BOSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today outlined progress within its pipeline programs and key milestones for 2025. “Reflecting on our accomplishments in 2024, we are proud of the advancements in our late-stage clinical programs, culminating in a strong presence at AES where we...

TOKYO, Jan. 13, 2025 (GLOBE NEWSWIRE) — Lead Real Estate Co., Ltd. (Nasdaq: LRE) (“LRE” or “the Company”), a Japanese real estate developer of luxury residential properties including single-family homes and condominiums across Tokyo, Kanagawa prefecture and Sapporo, today announced that in December 2024, it completed the sale and delivery of two newly built luxury income-producing condominium buildings in prime locations in Tokyo. A 3-unit property, Excelsior Nishi Azabu 2 Chome, in Minato-ku, Nishi Azabu, is made from reinforced concrete, has one basement floor and three floors above ground. It has a building area of 4,985 square feet and a land area of 2,238 square feet. A high-end residential neighborhood surrounded by traditional stores, Nishi Azabu has convenient access to financial centers and elegant shopping districts. The...

SAN CLEMENTE, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) — Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reports preliminary financial results for the fourth quarter and full fiscal year, for the period ended December 31, 2024. Preliminary financial resultsFourth quarter 2024 revenue is expected to total between $18.2 million and $18.4 million, as compared to approximately $15.3 million in the same period last year, reflecting an increase of approximately 20% compared to the same period last year. Full fiscal 2024 revenue is expected to total between $59.5 million and $59.7 million, as compared to approximately $50.3 million in the same period last year, reflecting an increase of approximately 19% compared to the same period last year. Cash...